9/12
10:18 am
cnsp
CNS Pharmaceuticals (NASDAQ:CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Medium
Report
CNS Pharmaceuticals (NASDAQ:CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
9/12
10:06 am
cnsp
Rating for CNSP
Medium
Report
Rating for CNSP
9/12
07:48 am
cnsp
CNS Pharmaceuticals upgraded to Buy from Hold at Maxim
Medium
Report
CNS Pharmaceuticals upgraded to Buy from Hold at Maxim